<DOC>
	<DOCNO>NCT01192412</DOCNO>
	<brief_summary>The investigator know approach treatment non-severe high blood pressure pregnancy well woman baby . In CHIPS Trial , investigator seek determine whether 'less tight ' control ( aim diastolic blood pressure [ dBP ] 100 mmHg ) , compare 'tight ' control ( aim diastolic blood pressure [ dBP ] 85 mmHg ) decrease risk adverse baby outcome without increase risk problem mother .</brief_summary>
	<brief_title>The CHIPS Trial ( Control Hypertension In Pregnancy Study )</brief_title>
	<detailed_description>Primary research question : For pregnant woman non-severe , non-proteinuric maternal hypertension 14-33 week , 'less tight ' control ( target diastolic blood pressure [ dBP ] 100 mmHg ) versus 'tight ' control ( target dBP 85 mmHg ) increase ( decrease ) likelihood pregnancy loss Neonatal Intensive Care Unit ( NICU ) admission great 48 hour ? Secondary research question : Will 'less tight ' versus 'tight ' control increase ( decrease ) likelihood serious maternal complication ? Other research question : Will 'less tight ' versus 'tight ' control : 1 . Increase ( decrease ) likelihood serious perinatal complication ? 2 . Increase ( decrease ) likelihood severe hypertension pre-eclampsia ? 3 . Increase ( decrease ) likelihood maternal satisfaction care ? 4 . Result significant change dBP health care cost ? Treatment Allocation : Eligible woman randomise centrally either 'less tight ' control ( aim dBP 100mmHg ) 'tight ' control ( aim dBP 85mmHg ) hypertension . Randomisation stratify centre type hypertension ( pre-existing gestational ) . - In 'less tight ' control group , dBP ≥105mmHg , antihypertensive medication must start increase dose . - In 'tight ' control group , dBP ≤80mmHg , antihypertensive medication must decrease dose discontinue . - In group , centre provide usual care . Data collect potential co-interventions ( e.g. , hospitalisation , bedrest ) . Outcomes : Primary : Pregnancy loss ( miscarriage ectopic pregnancy , pregnancy termination , stillbirth , neonatal death ) high level neonatal care &gt; 48 hour first 28 day life prior primary hospital discharge , whichever later . Secondary : One/more serious maternal complication ( ) six week postpartum . Follow-up : Compliance ( dBP antihypertensive dose ) assess within 4 week randomisation . Outcome data collect woman 's ( baby 's ) hospital stay birth ( loss ) . Women contact 6 12 week delivery ( loss ) , preterm baby , baby 36 week correct gestational age enquire satisfaction care major maternal/neonatal morbidity follow hospital discharge .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pregnancy-Induced</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>1 . Preexisting gestational hypertension ( preexist hypertension dBP great equal 90 mmHg pregnancy 20 week ' gestation ; gestational hypertension dBP great equal 90 mmHg develop 20 week ) 2. dBP 90 105 mmHg NOT TAKING antihypertensive therapy , dBP 85 105 mmHg TAKING antihypertensive therapy 3 . Live foetus ( confirm Doptone assessment foetal heart tone within one week randomisation ) 4 . Gestational age 14 33+6 week ( measure last menstrual period date ultrasound ) 1 . Severe systolic hypertension ( define systolic blood pressure [ sBP ] great equal 160 mmHg randomisation ) 2 . Proteinuria ( define great equal 0.3 g/d 24 hour urine collection , 24 hour urine collection available , urinary protein : creatinine ratio great equal 30 mg/mmol urinary dipstick great equal 2+ ) 3 . Use angiotensin convert enzyme ( ACE ) inhibitor great equal 14+0 week ' gestation 4 . Contraindication either arm trial pregnancy prolongation 5 . Known multiple gestation 6 . Known lethal major foetal anomaly 7 . Plan terminate pregnancy 8 . Prior participation CHIPS</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>hypertension</keyword>
	<keyword>pregnancy</keyword>
	<keyword>antihypertensive therapy</keyword>
	<keyword>perinatal outcome</keyword>
	<keyword>maternal outcome</keyword>
	<keyword>Non-severe , non-proteinuric pre-existing gestational hypertension pregnancy</keyword>
</DOC>